1. Home
  2. PCRX vs THS Comparison

PCRX vs THS Comparison

Compare PCRX & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • THS
  • Stock Information
  • Founded
  • PCRX 2006
  • THS 2021
  • Country
  • PCRX United States
  • THS United States
  • Employees
  • PCRX N/A
  • THS N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • THS Packaged Foods
  • Sector
  • PCRX Health Care
  • THS Consumer Staples
  • Exchange
  • PCRX Nasdaq
  • THS Nasdaq
  • Market Cap
  • PCRX 1.1B
  • THS 1.1B
  • IPO Year
  • PCRX 2011
  • THS N/A
  • Fundamental
  • Price
  • PCRX $24.65
  • THS $22.10
  • Analyst Decision
  • PCRX Buy
  • THS Hold
  • Analyst Count
  • PCRX 9
  • THS 6
  • Target Price
  • PCRX $30.11
  • THS $31.67
  • AVG Volume (30 Days)
  • PCRX 1.2M
  • THS 745.7K
  • Earning Date
  • PCRX 05-06-2025
  • THS 05-06-2025
  • Dividend Yield
  • PCRX N/A
  • THS N/A
  • EPS Growth
  • PCRX N/A
  • THS N/A
  • EPS
  • PCRX N/A
  • THS 0.51
  • Revenue
  • PCRX $700,966,000.00
  • THS $3,354,000,000.00
  • Revenue This Year
  • PCRX $9.48
  • THS $1.43
  • Revenue Next Year
  • PCRX $11.31
  • THS $1.68
  • P/E Ratio
  • PCRX N/A
  • THS $43.33
  • Revenue Growth
  • PCRX 3.85
  • THS N/A
  • 52 Week Low
  • PCRX $11.16
  • THS $21.46
  • 52 Week High
  • PCRX $31.67
  • THS $43.84
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 51.22
  • THS 31.24
  • Support Level
  • PCRX $24.10
  • THS $21.46
  • Resistance Level
  • PCRX $25.35
  • THS $23.83
  • Average True Range (ATR)
  • PCRX 1.49
  • THS 1.22
  • MACD
  • PCRX 0.01
  • THS -0.13
  • Stochastic Oscillator
  • PCRX 48.89
  • THS 10.37

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About THS Treehouse Foods Inc.

TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages and drink mixes (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.

Share on Social Networks: